Clinical Trial Update: To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of zoledronic acid (ZOMETA) for treating bone metastases in patients with stage IV nasopharyngeal cancer; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Nasopharyngeal Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-02